Global Virus Filtration Market – North America is expected to account for higher market share of more than 55% driven by well-established biotechnology and biopharmaceutical industry in the U.S.: Market Analysis and Forecast 2019 – 2026

Global Virus Filtration Market – North America is expected to account for higher market share of more than 55% driven by well-established biotechnology and biopharmaceutical industry in the U.S.: Market Analysis and Forecast 2019 – 2026

Market Scenario

Global Virus Filtration Market is expected to grow at a CAGR of 14% to reach US$ XX million in 2026. The growth is coupled with the rising prevalence of chronic diseases including cancer, diabetes, and autoimmune disorders. According to the International Agency for Research on Cancer, around 14.1 million new cancer cases were diagnosed worldwide in 2016 and this number is projected to reach 21.7 million by 2030. Thus, there is a growing demand for therapeutic biologics for the treatment of such chronic diseases, which consequently propel the demand for virus filtration products for R&D and manufacturing applications. Compliance with drug development & production regulatory frameworks such as Current Good Manufacturing Practice (cGMP) regulations is another main driver expected to boost the Global Virus Filtration Market. Virus safety of these products is ensured by manufacturers through various quality control measures such as monitoring and quality check of raw materials, validation & implementation of efficient virus clearance technology, as well as validation of the final product for the absence of virus contamination. Thus, the demand for these products is very high for manufacturing and R&D practices. North America virus filtration market dominated the overall sector and is expected to maintain its dominance during the study period. The well-established biotechnology and biopharmaceutical industry in the U.S. has spurred the demand for advanced viral clearance products for R&D and biologics production in this region. Europe was the second largest market due to high demand for innovative virus filtration products for research and biologics development & production. In addition, highly developed healthcare infrastructure and investment of a large amount of money in R&D, primarily in Germany, UK, and France are expected to drive the regional market. The consumables segment accounted for the largest share of the market in 2017 and is expected to showcase lucrative growth over the forecast period owing to the increased usage of these virus filtration products. The rising focus on the development of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, and stem cell products is expected to boost the demand for consumables including reagents, kits, and membranes. Global Virus Filtration Market,  By End-Use

Global Virus Filtration Market Segmentation

•Global Virus Filtration Market,  By Product o Consumables

 Kits and reagents  Others o Instruments  Filtration systems  Chromatography systems o Services

•Global Virus Filtration Market,  By End-Use

o Biopharmaceutical & biotechnology companies o Contract research organizations o Medical devices companies o Academic institutes & research laboratories

•Global Virus Filtration Market,  By Application

o Biologicals  Vaccines and therapeutics  Blood and blood products  Cellular and gene therapy products  Tissue and tissue products  Stem cell products o Medical devices o Water purification o Air purification The above data will be provided for following regions/countries from 2018-2026 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico Middle East and Africa o South Africa o Saudi Arabia What information is covered in report? • Actual market numbers from 2017-2018, estimates and forecasts from 2018 to 2026 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape •  Competitive landscape, 2017. Global Cold Pain Therapy Market 

Table of Contents

Global Virus Filtration Market

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Virus Filtration Market overview 2.1.1. By Product 2.1.2. By End-Use 2.1.3. By Applications Chapter 3 Global Virus Filtration Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Increasing demand for biological products 3.2.1.2. Rising prevalence of chronic diseases 3.2.2. Market Restrains 3.2.2.1. Highly consolidated market 3.2.2.2. Stringent regulations for filtration product validation 3.3. Market share analysis 3.3.1. By Product 3.3.2. By End-Use 3.3.3. By Applications 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Virus Filtration Market, By Products 4.1. Key segment trends 4.2. Consumables 4.2.1. Market size, by region, 2013 - 2024 4.3. Kits and reagents 4.3.1. Market size, by region, 2019-2026 4.4. Others 4.4.1. Market size, by region, 2019-2026 4.5. Instruments 4.5.1. Market size, by region, 2019-2026 4.6. Filtration systems 4.6.1. Market size, by region, 2019-2026 4.7. Chromatography systems 4.7.1. Market size, by region, 2019-2026 4.8. Services 4.8.1. Market size, by region, 2019-2026 4.8.2. Key Trends in Global Virus Filtration Market Chapter 5 Virus Filtration Market, By Applications 5.1. Key segment trends 5.2. Biologicals 5.2.1. Market size, by region, 2013 - 2024 5.3. Vaccines and therapeutics 5.3.1. Market size, by region, 2019-2026 5.4. Blood and blood products 5.4.1. Market size, by region, 2019-2026 5.5. Cellular and gene therapy products 5.5.1. Market size, by region, 2019-2026 5.6. Tissue and tissue products 5.6.1. Market size, by region, 2019-2026 5.7. Stem cell products 5.7.1. Market size, by region, 2019-2026 5.8. Medical devices 5.8.1. Market size, by region, 2019-2026 5.9. Water purification 5.9.1. Market size, by region, 2019-2026 5.10. Air purification 5.10.1. Market size, by region, 2019-2026 Chapter 6 Virus Filtration Market, By End-Use 6.1. Key segment trends 6.2. Biopharmaceutical & biotechnology companies 6.2.1. Market size, by region, 2013 - 2024 6.3. Contract research organizations 6.3.1. Market size, by region, 2019-2026 6.4. Medical devices companies 6.4.1. Market size, by region, 2019-2026 6.5. Academic institutes & research laboratories 6.5.1. Market size, by region, 2019-2026 Chapter 7 Virus Filtration Market, By Region 7.1. Key regional trends 7.2. North America 7.2.1. Market size, by country, 2019-2026 7.2.2. Market size, by end-use, 2019-2026 7.2.3. Market size, by products, 2019-2026 7.2.4. Market size, by applications, 2019-2026 7.2.5. U.S. 7.2.5.1. Market size, by end-use, 2019-2026 7.2.5.2. Market size, by products, 2019-2026 7.2.5.3. Market size, by applications, 2019-2026 7.2.6. Canada 7.2.6.1. Market size, by end-use, 2019-2026 7.2.6.2. Market size, by products, 2019-2026 7.2.6.3. Market size, by applications, 2019-2026 7.3. Europe 7.3.1. Market size, by country, 2019-2026 7.3.2. Market size, by end-use, 2019-2026 7.3.3. Market size, by products, 2019-2026 7.3.4. Market size, by applications, 2019-2026 7.3.5. Germany 7.3.5.1. Market size, by end-use, 2019-2026 7.3.5.2. Market size, by products, 2019-2026 7.3.5.3. Market size, by applications, 2019-2026 7.3.6. UK 7.3.6.1. Market size, by end-use, 2019-2026 7.3.6.2. Market size, by products, 2019-2026 7.3.6.3. Market size, by applications, 2019-2026 7.3.7. France 7.3.7.1. Market size, by end-use, 2019-2026 7.3.7.2. Market size, by products, 2019-2026 7.3.7.3. Market size, by applications, 2019-2026 7.3.8. Spain 7.3.8.1. Market size, by end-use, 2019-2026 7.3.8.2. Market size, by products, 2019-2026 7.3.8.3. Market size, by applications, 2019-2026 7.3.9. Italy 7.3.9.1. Market size, by end-use, 2019-2026 7.3.9.2. Market size, by products, 2019-2026 7.3.9.3. Market size, by applications, 2019-2026 7.4. Asia Pacific 7.4.1. Market size, by country, 2019-2026 7.4.2. Market size, by end-use, 2019-2026 7.4.3. Market size, by products, 2019-2026 7.4.4. Market size, by applications, 2019-2026 7.4.5. India 7.4.5.1. Market size, by end-use, 2019-2026 7.4.5.2. Market size, by products, 2019-2026 7.4.5.3. Market size, by applications, 2019-2026 7.4.6. China 7.4.6.1. Market size, by end-use, 2019-2026 7.4.6.2. Market size, by products, 2019-2026 7.4.6.3. Market size, by applications, 2019-2026 7.4.7. Japan 7.4.7.1. Market size, by end-use, 2019-2026 7.4.7.2. Market size, by products, 2019-2026 7.4.7.3. Market size, by applications, 2019-2026 7.4.8. Australia 7.4.8.1. Market size, by end-use, 2019-2026 7.4.8.2. Market size, by products, 2019-2026 7.4.8.3. Market size, by applications, 2019-2026 7.5. Latin America 7.5.1. Market size, by country, 2019-2026 7.5.2. Market size, by end-use, 2019-2026 7.5.3. Market size, by products, 2019-2026 7.5.4. Market size, by applications, 2019-2026 7.5.5. Argentina 7.5.5.1. Market size, by end-use, 2019-2026 7.5.5.2. Market size, by products, 2019-2026 7.5.5.3. Market size, by applications, 2019-2026 7.5.6. Brazil 7.5.6.1. Market size, by end-use, 2019-2026 7.5.6.2. Market size, by products, 2019-2026 7.5.6.3. Market size, by applications, 2019-2026 7.5.7. Mexico 7.5.7.1. Market size, by end-use, 2019-2026 7.5.7.2. Market size, by products, 2019-2026 7.5.7.3. Market size, by applications, 2019-2026 7.6. Middle East and Africa 7.6.1. Market size, by country, 2019-2026 7.6.2. Market size, by end-use, 2019-2026 7.6.3. Market size, by products, 2019-2026 7.6.4. Market size, by applications, 2019-2026 7.6.5. South Africa 7.6.5.1. Market size, by end-use, 2019-2026 7.6.5.2. Market size, by products, 2019-2026 7.6.5.3. Market size, by applications, 2019-2026 7.6.6. Saudi Arabia 7.6.6.1. Market size, by end-use, 2019-2026 7.6.6.2. Market size, by products, 2019-2026 7.6.6.3. Market size, by applications, 2019-2026 Chapter 8 Consolidations 8.1. Mergers and Acquisitions 8.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 8.3. Patent Analysis 8.4. Key players 8.4.1. Merck KGaA 8.4.1.1. Company overview 8.4.1.2. Key financials 8.4.1.3. Product landscape 8.4.1.4. Strategic initiatives 8.4.1.5. SWOT analysis 8.4.2. General Electric Company 8.4.2.1. Company overview 8.4.2.2. Key financials 8.4.2.3. Product landscape 8.4.2.4. Strategic initiatives 8.4.2.5. SWOT analysis 8.4.3. Thermo Fisher Scientific Inc. 8.4.3.1. Company overview 8.4.3.2. Key financials 8.4.3.3. Product landscape 8.4.3.4. Strategic initiatives 8.4.3.5. SWOT analysis 8.4.4. Lonza Group Ltd. 8.4.4.1. Company overview 8.4.4.2. Key financials 8.4.4.3. Product landscape 8.4.4.4. Strategic initiatives 8.4.4.5. SWOT analysis 8.4.5. Pall Corporation 8.4.5.1. Company overview 8.4.5.2. Key financials 8.4.5.3. Product landscape 8.4.5.4. Strategic initiatives 8.4.5.5. SWOT analysis 8.4.6. Charles River Laboratories International, Inc. 8.4.6.1. Company overview 8.4.6.2. Key financials 8.4.6.3. Product landscape 8.4.6.4. Strategic initiatives 8.4.6.5. SWOT analysis 8.4.7. Sigma-Aldrich Corporation 8.4.7.1. Company overview 8.4.7.2. Key financials 8.4.7.3. Product landscape 8.4.7.4. Strategic initiatives 8.4.7.5. SWOT analysis 8.4.8. Sartorius AG 8.4.8.1. Company overview 8.4.8.2. Key financials 8.4.8.3. Product landscape 8.4.8.4. Strategic initiatives 8.4.8.5. SWOT analysis 8.4.9. Asahi Kasei Medical Co., Ltd. 8.4.9.1. Company overview 8.4.9.2. Key financials 8.4.9.3. Product landscape 8.4.9.4. Strategic initiatives 8.4.9.5. SWOT analysis 8.4.10. WuXi PharmaTech 8.4.10.1. Company overview 8.4.10.2. Key financials 8.4.10.3. Product landscape 8.4.10.4. Strategic initiatives 8.4.10.5. SWOT analysis 8.4.11. Sartorius 8.4.11.1. Company overview 8.4.11.2. Key financials 8.4.11.3. Product landscape 8.4.11.4. Strategic initiatives 8.4.11.5. SWOT analysis 8.4.12. Danaher 8.4.12.1. Company overview 8.4.12.2. Key financials 8.4.12.3. Product landscape 8.4.12.4. Strategic initiatives 8.4.12.5. SWOT analysis 8.4.13. GE Healthcare 8.4.13.1. Company overview 8.4.13.2. Key financials 8.4.13.3. Product landscape 8.4.13.4. Strategic initiatives 8.4.13.5. SWOT analysis 8.4.14. Clean Cells 8.4.14.1. Company overview 8.4.14.2. Key financials 8.4.14.3. Product landscape 8.4.14.4. Strategic initiatives 8.4.14.5. SWOT analysis 8.4.15. QIAGEN 8.4.15.1. Company overview 8.4.15.2. Key financials 8.4.15.3. Product landscape 8.4.15.4. Strategic initiatives 8.4.15.5. SWOT analysis 8.4.16. Agilent Technologies 8.4.16.1. Company overview 8.4.16.2. Key financials 8.4.16.3. Product landscape 8.4.16.4. Strategic initiatives 8.4.16.5. SWOT analysis 8.4.17. Bio-Rad Laboratories, Inc. 8.4.17.1. Company overview 8.4.17.2. Key financials 8.4.17.3. Product landscape 8.4.17.4. Strategic initiatives 8.4.17.5. SWOT analysis 8.4.18. Hoffmann-La Roche Ltd 8.4.18.1. Company overview 8.4.18.2. Key financials 8.4.18.3. Product landscape 8.4.18.4. Strategic initiatives 8.4.18.5. SWOT analysis 8.4.19. Pfizer Inc. 8.4.19.1. Company overview 8.4.19.2. Key financials 8.4.19.3. Product landscape 8.4.19.4. Strategic initiatives 8.4.19.5. SWOT analysis 8.4.20. Hospitech 8.4.20.1. Company overview 8.4.20.2. Key financials 8.4.20.3. Product landscape 8.4.20.4. Strategic initiatives 8.4.20.5. SWOT analysis 8.4.21. CSL Behring 8.4.21.1. Company overview 8.4.21.2. Key financials 8.4.21.3. Product landscape 8.4.21.4. Strategic initiatives 8.4.21.5. SWOT analysis 8.4.22. Illumina, Inc. 8.4.22.1. Company overview 8.4.22.2. Key financials 8.4.22.3. Product landscape 8.4.22.4. Strategic initiatives 8.4.22.5. SWOT analysis 8.4.23. Eppendorf AG 8.4.23.1. Company overview 8.4.23.2. Key financials 8.4.23.3. Product landscape 8.4.23.4. Strategic initiatives 8.4.23.5. SWOT analysis 8.4.24. PromoCell GmbH 8.4.24.1. Company overview 8.4.24.2. Key financials 8.4.24.3. Product landscape 8.4.24.4. Strategic initiatives 8.4.24.5. SWOT analysis 8.4.25. HiMedia Laboratories 8.4.25.1. Company overview 8.4.25.2. Key financials 8.4.25.3. Product landscape 8.4.25.4. Strategic initiatives 8.4.25.5. SWOT analysis

About This Report

Report ID10964
Category Healthcare
Published Dateoct 2019
No of Pages298
Contact Us
Call Now